Moreover, the enrichment of ATP-dependent chromatin remodeling and TF binding pathways suggests the presence of epigenetic silencing, which may inhibit tumor antigen presentation, promote immune escape, and facilitate the growth and survival of B-ALL cells by affecting intercellular signaling pathways [46,47]. The gene discussed is TF; the disease is acute lymphoblastic leukemia.